209 related articles for article (PubMed ID: 10726353)
1. [A comparative efficacy study of the preoperative use of GnRH agonists in women with uterine fibromyomas].
Nikolov A; Karag'ozov I
Akush Ginekol (Sofiia); 1999; 38(4):38-42. PubMed ID: 10726353
[TBL] [Abstract][Full Text] [Related]
2. GnRH agonists before surgery for uterine leiomyomas. A review.
Crosignani PG; Vercellini P; Meschìa M; Oldani S; Bramante T
J Reprod Med; 1996 Jun; 41(6):415-21. PubMed ID: 8799917
[TBL] [Abstract][Full Text] [Related]
3. Goserelin acetate 10.8 mg plus iron versus iron monotherapy prior to surgery in premenopausal women with iron-deficiency anemia due to uterine leiomyomas: results from a Phase III, randomized, multicenter, double-blind, controlled trial.
Muneyyirci-Delale O; Richard-Davis G; Morris T; Armstrong J
Clin Ther; 2007 Aug; 29(8):1682-91. PubMed ID: 17919549
[TBL] [Abstract][Full Text] [Related]
4. Clinical efficacy of goserelin (Zoladex) in the treatment of uterine myomas in infertile patients.
Kopitović V; Bujas M; Fistes Topalski N; Pjević M; Ilić D; Kapamadzija A; Bujas I
Med Pregl; 2001; 54(7-8):339-46. PubMed ID: 11905182
[TBL] [Abstract][Full Text] [Related]
5. A randomized, controlled clinical trial comparing the effects of aromatase inhibitor (letrozole) and gonadotropin-releasing hormone agonist (triptorelin) on uterine leiomyoma volume and hormonal status.
Parsanezhad ME; Azmoon M; Alborzi S; Rajaeefard A; Zarei A; Kazerooni T; Frank V; Schmidt EH
Fertil Steril; 2010 Jan; 93(1):192-8. PubMed ID: 19135657
[TBL] [Abstract][Full Text] [Related]
6. [Preoperative reduction of uterine leiomyoma by the GnRH-analog goserelin (zoladex)].
Hackenberg R; Gesenhues T; Deichert U; Duda V; Sturm G; Schulz KD
Geburtshilfe Frauenheilkd; 1990 Feb; 50(2):136-9. PubMed ID: 2138580
[TBL] [Abstract][Full Text] [Related]
7. GnRH agonist therapy before myomectomy or hysterectomy.
Gutmann JN; Corson SL
J Minim Invasive Gynecol; 2005; 12(6):529-37; quiz 528, 538-9. PubMed ID: 16337584
[No Abstract] [Full Text] [Related]
8. Prospective randomised trial comparing gonadotrophin-releasing hormone analogues with triple tourniquets at open myomectomy.
Al-Shabibi N; Chapman L; Madari S; Papadimitriou A; Papalampros P; Magos A
BJOG; 2009 Apr; 116(5):681-7. PubMed ID: 19191779
[TBL] [Abstract][Full Text] [Related]
9. [Treatment of uterine leiomyoma with depot leuprorelin acetate (Enantone-Gyn monthly depot). Effect on leiomyoma volume and operability. German Leuprorelin Study Group].
Stolz W; Pfützenreuter N
Zentralbl Gynakol; 1997; 119(10):468-75. PubMed ID: 9432825
[TBL] [Abstract][Full Text] [Related]
10. [Myomectomy performed after Zoladex preparation with subsequent repair of the uterine wall via a balloon catheter in the uterine cavity].
Nikolov A; Raĭcheva R; Maĭnkhard K
Akush Ginekol (Sofiia); 1998; 37(1):55-7. PubMed ID: 9770805
[No Abstract] [Full Text] [Related]
11. [Effect of GnRH analogues pre-treatment on myomectomy outcomes in reproductive age women].
Hudecek R; Ivanová Z; Smerdová M; Pánková S; Krajcovicová R
Ceska Gynekol; 2012 Apr; 77(2):109-17. PubMed ID: 22702067
[TBL] [Abstract][Full Text] [Related]
12. [GnRH agonists and antagonists in the preoperative therapy of uterine fibroids: literature review].
De Falco M; Pollio F; Pontillo M; Ambrosino E; Busiello A; Carbone IF; Ciociola F; Di Nardo MA; Landi L; Di Lieto A
Minerva Ginecol; 2006 Dec; 58(6):553-60. PubMed ID: 17108883
[TBL] [Abstract][Full Text] [Related]
13. Presurgical treatment of uterine fibroids by using gonadotropin-releasing hormone agonists.
Falsetti L; Mazzani MD; Rubessa S; Ruggeri C
Acta Eur Fertil; 1992; 23(1):29-32. PubMed ID: 1293897
[TBL] [Abstract][Full Text] [Related]
14. Leiomyoma pseudocapsule after pre-surgical treatment with gonadotropin-releasing hormone agonists: relationship between clinical features and immunohistochemical changes.
De Falco M; Staibano S; Mascolo M; Mignogna C; Improda L; Ciociola F; Carbone IF; Di Lieto A
Eur J Obstet Gynecol Reprod Biol; 2009 May; 144(1):44-7. PubMed ID: 19297072
[TBL] [Abstract][Full Text] [Related]
15. [The use of Ovestin to overcome the side effects of treatment with GnRH agonists (Zoladex)].
Ivanov S; Ivanov S
Akush Ginekol (Sofiia); 1998; 37(4):25-6. PubMed ID: 10360048
[TBL] [Abstract][Full Text] [Related]
16. The value of pre-operative treatment with GnRH analogues in women with submucous fibroids: a double-blind, placebo-controlled randomized trial.
Mavrelos D; Ben-Nagi J; Davies A; Lee C; Salim R; Jurkovic D
Hum Reprod; 2010 Sep; 25(9):2264-9. PubMed ID: 20663795
[TBL] [Abstract][Full Text] [Related]
17. Potential cost savings using GnRH agonists as preoperative therapy for uterine leiomyomas.
Saltiel E
Formulary; 1995 Sep; 30(9):532-4, 542. PubMed ID: 10161243
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of tibolone as "add-back therapy" in conjunction with a gonadotropin-releasing hormone analogue in the treatment of uterine fibroids.
Morris EP; Rymer J; Robinson J; Fogelman I
Fertil Steril; 2008 Feb; 89(2):421-8. PubMed ID: 17572410
[TBL] [Abstract][Full Text] [Related]
19. [Hysteroresection of submucous myomas after treatment with zoladex].
Tiufekchieva E; Nikolov A
Akush Ginekol (Sofiia); 2006; 45(1):19-24. PubMed ID: 16637313
[TBL] [Abstract][Full Text] [Related]
20. Removal of fibromyomas by laparoscopic surgery after preoperative GnRH analogue--an alternative to abdominal hysterectomy or myomectomy.
Wood C; Maher P
Aust N Z J Obstet Gynaecol; 1996 Nov; 36(4):464-8. PubMed ID: 9006835
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
